Morgan Stanley Downgrades HUTCHMED (China) to Underweight, Lowers Price Target to $13.75
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Morgan Stanley analyst Jack Lin downgrades HUTCHMED (China) (NASDAQ:HCM) from Equal-Weight to Underweight and lowers the price target from $18 to $13.75.
Morgan Stanley analyst Jack Lin downgrades HUTCHMED (China) (NASDAQ:HCM) from Equal-Weight to Underweight and lowers the price target from $18 to $13.75.